Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2007 Vol. 2
p
 
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 2
Nanotech 2007 Vol. 2
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 2
 
Chapter 4: Biomarkers & Nanoparticles
 

Gatifloxacin Nanoparticles For Ophthalmic Delivery

Authors:S.K. Motwani, F.J. Ahmad, Z. Iqbal, S. Talegaonkar and R.K. Khar
Affilation:Faculty of Pharmacy, Hamdard University, IN
Pages:310 - 312
Keywords:nanoparticles, gatifloxacin, opthalmic, chitasan
Abstract:Biodegradable colloidal nanoparticles of Poly (lactide-co-glycolide) (PLGA) have received considerable attention as a possible means of delivering drugs because of their biocompatibility and resorbability through natural pathways. As the ocular efficacy of drugs is greatly influenced by the corneal contact time, the most promising approach to increase ocular bioavailability is to increase pre-corneal residence time by using adequate drug delivery systems. The aim of the present research work was to formulate cationically modified PLGA nanoreservoir systems of Gatifloxacin for ocular delivery. A modified Emulsion-diffusion-evaporation technique was used to prepare biodegradable and biocompatible PLGA nanoreservoir systems, stabilized by polyvinyl alcohol (PVA) and chitosan (CS). The prepared nanospheres were characterized for particle size and size distribution by dynamic light scattering, zetapotential, drug content & encapsulation efficiency and in vitro drug release profile (phosphate buffer pH 7.4, 50 ml). Surface properties of the nanospheres were studied by Transmission Electron Microscopy and Atomic Force Microscopy. The designed nanospheres have average particle size from 318-556 nm (polydispersity from 0.325-0.489) and zetapotential from 21-36 mV at pH 7.4. The cationically charged chitosan coated PLGA nanoparticles, which can interact with extraocular structures because of their negative charge, would increase the concentration of the drug by increased penetration through corneal epithelium.
Gatifloxacin Nanoparticles For Ophthalmic DeliveryView paper
ISBN:1-4200-6183-6
Pages:838
Hardcopy:$199.99
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
Upcoming Events
Nanotech 2009
Cleantech 2009
BioNano 2009
TechConnect Summit
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact